Summary
Autoimmune diseases affect 10% or more of the North American and European populations. In organ-specific autoimmune diseases, an organ is targeted by an aggressive immune response, which can damage and even destroy it. Type 1 diabetes mellitus (T1DM), one such organ-specific autoimmune disease, is because of the destruction of the insulin-secreting beta cells in the islets of Langerhans of the pancreas. T1DM is because of the interaction of genetic and non-genetic factors thought to induce an immune response, which destroys insulin secretory cells over months, even years. We present the orthodox position regarding the cause of autoimmune T1DM but also emphasize where that orthodox is not based on a firm footing. We discuss the nature of the disease and how we can predict it with a degree of certainty and how we are now trying to modulate the disease process. Lessons learned from autoimmune diabetes could be relevant to other autoimmune diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Leslie RD, Delli Castelli M. Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 2004; 53:3033–40.
Foulis AK, Stewart JA. The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 1984; 26:456–61.
Itoh N, Hanafusa T, Miyazaki A, Miyagawa J, Yamagata K, Yamamoto K, Waguri M, Imagawa A, Tamura S, Inada M. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993; 92: 2313–22.
Field LL: Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 2002; 45:21–35.
Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS. Type 1 diabetes genetic consortium. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005; 54:2992–3001.
Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, Leslie RDG. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 2001; 44:354–362.
Kumar D, Gemayel NS, Deapen D, Kapadia D, Yamashita PH, Lee M, Dwyer JH, Roy-Burman P, Bray GA, Mach TM: North-American twins with IDDM: genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 1993; 42:1351–63.
Meyer D, Thomson G: How selection shapes variation of the human major histocompatibility complex: a review. Ann Hum Genet 2001; 65:1–26.
Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP. Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1. J Clin Endocrinol Metab 2000; 85:1255–60.
Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, Salmela PI, Knip M. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000; 23:1326–32.
Vanderwalle CL, Cecraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, and the Belgian Diabetes Register. Insulin antibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*03100-DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years but not at onset between age 10 and 40 years. Diabetologia 1993; 36:1155–62.
Hamalanian A-M, Savola K, Kulmala PK, Koskela P, Akerblom HK, Knip M, and the Finnish TRIGR Study Group. Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Clin Exp Immunol 2001; 126:231–6.
Wang WY, Barrate BJ, Clayton DG, Todd JA. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 2005; 6:109–18.
Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RDG: Twins: mirrors of the immune system. Immunol Today 2000; 21:342–7.
Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 2003; 52:1052–5.
Kyvick KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, Mckinney PA, Michalkova D, Ostrauskas R, Raymond NT. The epidemology of type I diabetes mellitus is not the same in young adults as in children. Diabetologia 2004; 47:377–84.
Baker JM. Type 1 diabetes associated autoimmunity: natural history, genetic associations and screening. J Clin Endocrinol Metab 2006; 91:1210–1217.
Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, Wang J, Dong Z, Brusko T, Atkinson M, Pozzilli P, Zeidler A, Raffel LJ, Jacob CO, Park Y, Serrano-Rios M, Larrad MT, Zhang Z, Garchon HJ, Bach JF, Rotter JI, She JX, Wang CY. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. Nat Genet 2004; 36:837–41.
Warram JH, Krolewski AS, Gottlieb MS, Kahn CR. Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 1984; 311:149–52.
Bleich D, Polak M, Eisenbarth GS, Jackson RA: Decreased risk of type 1 diabetes in offspring of mothers who acquire diabetes during adrenarchy. Diabetes 1993; 42:1433–9.
Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911–20.
Joslin EP. The treatment of diabetes mellitus with observations based upon three thousand cases, 3rd edn. Philadelphia and New York, Lea and Febiger, 1923. Nutr Rev. 1983; 41:187–9.
Sultz HA. Childhood diabetes mellitus. In: Long-Term Childhood Illness. Sultz HA Ed. Pittsburg, PA, University of Pittsburg Press, p.223–48, 1972.
Schoenle EJ, Lang-Muritano M, Gschwend S, Laimbacher J, Mullis PE, Torresani T, Biason-Lauber A, Molinari L. Epidemiology of type 1 diabetes. Diabetologia 2001; 44:286–9.
Bodansky HJ, Saines A, Stephenson C, Haigh D, Cartwright R. Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. BMJ 1992; 304:1020–2.
Zung A, Elizur MN, Weintrob T. Bistritzer, Hanukoglu A, Zadik Z, Phillip M, Miller K, Koren IC. Brautbar and S Israel. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment. Hum Immunol 2004; 65:1463–8.
Staines A, Hanif S, Ahmed S, Mckinney PA, Shera S, Bodansky HJ. Incidence of insulin-dependent diabetes mellitus in Karachi, Pakistan. Arch Dis Child 1997; 76:121–3.
Hermann R, Knip M, Veijola R, Simell O, Laine AP, Akerblom HK, Groop PH, Forsblom C, Pettersson-Fernholm K, Ilonen J. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 2003; 46:420–5.
Pundziute-Lycka A, Dahlquist G, Nystrom L, Amqvist H, Bjork E, Blohme G, Bolinder J, Eriksson JW, Sundkvist G, Ostman J, Swedish Chidhood Diabetes Study Group. The incidence of type 1 diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 2002; 45:783–91.
Weets I, Leeuw IH, Du Caju MV, Rooman R, Keymeulen B, Mathieu C, Rottiers R, Daubresse JC, Rocour-Brumoul D, Pipeleers DG, Gorus FK, Belgian Diabetes Registry. The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation. Diabetes Care 2002; 25:840–6.
Hypponen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK, Childhood Diabetes in Finland Study Group. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000; 23:1755–60.
Bruining GJ. Association between infant growth before onset of juvenile type 1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes: Lancet 2000; 356:655–6.
Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testing the accelerator hypothesis; the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 2003; 26:2865–70.
Hawa MI, Fava D, Medici F, Deng YJ, Notkins AL, De Mattia G, Leslie RD. Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality. Diabetes Care 2000; 23:228–33.
Muntoni S, Fonte MT, Stoduto S, Marietti G, Bizzarri C, Crino A, Ciampalini P, Multari G, Suppa MA, Matteoli MC, Lucentini L, Sebastiani LM, Visalli N, Pozzilli P, Boscherini B, Muntoni S. Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 1997; 349:160–2.
Bingley PJ, Douek IF, Rogers CA, Gale EA. Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study. BMJ 2000; 321:420–4.
Dahlquist G, Kallen B: Maternal-child blood group incompatability and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35:671–5.
Dahlquist G, Ivarsson S, Lindberg B, Forsgren M: Maternal enteroviral infection during pregnancy asa risk factor for childhood IDDM. Diabetes 1995; 44:408–13.
Viskari H, Ludvigsson J, Uibo R, Salur L, Marciulionyte D, Hermann R, Soltesz G, Fuchtenbusch M, Ziegler AG, Kondrashova A, Romanov A, Kaplan B, Laron Z, Koskela P, Vesikari T, Huhtala H, Knip M, Hyoty H. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 2005; 48:1280–7.
Knip M. Cow’s milk and the new trials for prevention of type I diabetes. J Endocrinol Invest 2003; 26:265–7.
Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 2001; 358:1500–3.
Dahlquist GG, Blom LG, Persson LA, Sandstrom AI, Wall SG: Dietary factors and the risk of developing insulin dependent diabetes in childhood. BMJ 1990; 300:1302–6.
Parslow RC, McKinney PA, Law GR, Staines A, Williams R, Bodansky HJ. Incidence of childhood diabetes mellitus in Yorkshire, northern England, is associated with nitrate in drinking water: an ecological analysis. Diabetologia 1997; 40:550–6.
Bellacosa A. Genetic hits and mutation rate in colorectal tumorigenesis: Versatility of Knudson’s theory and implications for cancer prevention. Genes Chromosomes Cancer 2003; 38:382–8.
Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5:601–4.
McEvoy RC, Fedun B, Cooper LZ, Thomas NM, Rodriguez de Cordoba S, Rubinstein P, Ginsberg-Fellner F. Children at high risk of diabetes mellitus: New York studies of families with diabetes and of children with congenital rubella syndrome. Adv Exp Med Biol 1988; 246:221–7.
Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173–9.
Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002; 115:18–29.
Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes. 2005; 54 (Suppl 2):S125–36.
Fears WB. The rat poison Vacor. N Engl J Med 1980; 15;302:1147.
Gerstein HC, Simpson JR, Atkinson S, Taylor DW, VanderMeulen J. Feasibility and acceptability of a proposed infant feeding intervention trial for the prevention of type I diabetes. Diabetes Care 1995; 18:940–2.
Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 1993; 14: 426–30.
Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151–6.
Lan MS, Wasserfall C, Maclaren NK, Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1996; 93:6367–70.
Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222:1337–9.
Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993; 34: 1243–4.
Sibley RK, Sutherland DE, Goetz F, Michael AF. Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 1985; 53:132–44.
Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, for the Cyclosporine/Diabetes French Study Group. Cyclosporine increases the rate and length of remissions in insulin dependent diabetes of recent onset: results of a multicentre double-blind trial. Lancet 1986; 2: 119–24.
World Health Organization. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006 (Suppl 1):S43–S48.
Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342:301–7.
Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 2004; 101:17539–44.
Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC. Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 2005; 48:2206–12.
Palmer JP, Hampe CS, Chiu H, Goel A, Brooks-Worrell BM. Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age? Diabetes 2005; 54 (Suppl 2):S62–7.
Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R. 1997. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet; 350:1288–93.
Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R for the UK Prospective Diabetes Study (UKPDS) Group 1999 Genetic heterogeneity of autoimmune diabetes: age at presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 1999; 42:608–16.
Ohtsu S, Takubo N, Kazahari M, Nomoto K, Yokota F, Kikuchi N, Koike A, Matsuura N. Yokota F. Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children. Pediatr Diabetes 2005; 6:221–9.
Kobayashi T, Tanaka S, Okubo M, Nakanishi K, Murase T, Lernmark A. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes. J Clin Endocrinol Metab 2003; 88:4768–75.
Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 1999; 48:460–8.
Lindberg B, Ivarsson S-A, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark A. Islet autoantibodies in cord blood from children who developed type 1 (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia 1999; 42:181–7.
Hamalanian A-M, Savola K, Kulmala PK, Koskela P, Akerblom HK, Knip M and the Finnish TRIGR study group. Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Clin Exp Immunol 2001; 126:231–6.
Koczwara K, Bonifacio E, Ziegler A-G. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 2004; 53:1–4.
Leslie RDG, Elliott RB. Early environmental events as a cause of IDDM. Evidence and implications. Diabetes 1994; 43:843–50.
Kupila A, Keskinen P, Simell T, Erkkila S, Arvilommi P, Korhonen S, Kimpimaki T, Sjoroos M, Ronkainen M, Ilonen J, Knip M, Simell O. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 2002; 51:646–51.
Wong FS, Janeway CA Jr. The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. Res Immunol 1997; 148:327–32.
Roep BO. T-cell responses to autoantigens in IDDM. The search for the Holy Grail. Diabetes 1996; 45(9):1147–56.
Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391:177–81.
Pipeleers D, Ling Z: Pancreatic β cells in insulin-dependent diabetes. Diabetes Metab Rev 1992; 8:209–227.
Kent SC, Chen Y, Bregoli L, Clemmings SM, Kenyon NS, Ricordi C, Hering BJ, Hafler DA. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005; 435:224–8.
Lohmann T, Hawa M, Leslie RD, Lane R, Picard J, Londei M. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. Lancet 2000; 356:31–5.
Mauricio, D., and Mandrup-Poulsen, T. Apoptosis and the pathogenesis of IDDM: a question of life and death. Diabetes 1998; 47:1537–43.
Greenbaum CJ, Cuthbertson D, Krischer JP, Disease Prevention Trail of Type 1 Diabetes Study Group. Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 2001; 50:470–6.
Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkila S, Savolainen H, Arvilommi P, Simell T, Ilonen J, Knip M, Simell O. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes. Diabetologia 2002; 45:1639–48.
The DCCT Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987; 65:30–6.
Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Hawa M, Leslie RD. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes Metabolism 1998; 47:1205–1210.
Hosszufalusi N, Vatay A, Rajczy K, Prohaszka Z, Pozsonyi E, Horvath L, Grosz A, Gero L, Madacsy L, Romics L, Karadi I, Fust G, Panczel P. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 2003; 26:452–7.
The DCCT Research Group. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 1987; 65:30–6.
Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup-Poulsen T, Mahon J. Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care 1992; 15:66–74.
Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H, Leslie RD. No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. Diabetes Care 2005; 28:1415–8.
Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004; 47:1661–7.
Zinman B, Kahn SE, Haffner SM, O’Neill MC, Heise MA, Freed MI; ADOPT Study Group. Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 2004; 53:3193–200.
Bingley PJ, Bonifacio E, Gale EA. Can we really predict IDDM? Diabetes 1993; 42:213–20.
Gorus FK. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Diabetes Metab Rev 1997; 13:247–74.
Fava D, Gardner S, Pyke D, Leslie RD. Evidence that the age at diagnosis of IDDM is genetically determined. Diabetes Care 1998; 21:925–9.
Bruining GJ: Association between infant growth before onset of juvenile type 1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes. Lancet 2000; 356:655–6.
Gale EA. Spring harvest? Reflections on the rise of type 1 diabetes. Diabetologia 2005; 48:2445–50.
Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus. Diabet Med 1998; 15:844–50.
Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004; 53:250–64.
Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 1993; 16:902–10.
Carlsson A, Sundkvist G, Groop L, Tuomi T. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 2000; 85:76–80.
Behme MT, Dupre J, Harris SB, Hramiak IM, Mahon JL. Insulin resistance in latent autoimmune diabetes of adulthood. Ann N Y Acad Sci 2003; 1005:374–7.
Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of disease. J Clin Invest 2001; 108:1417–22.
Kulmala P, Savola K, Petersen JS, Vahasalo P, Karjalainen J, Lopponen T, Dyrberg T, Akerblom HK, Knip M Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. J Clin Invest 1998; 101:327–36.
Diabetes Prevention Trial–Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346:1685–91.
Knip M. Cow’s milk and the new trials for prevention of type I diabetes. J Endocrinol Invest 2003; 26:265–7.
Stene LC, Barriga K, Norris JM, Hoffman M, Klingensmith G, Erlich HA, Eisenbarth GS, Rewers M. Symptoms of common maternal infections in pregnancy and risk of islet autoimmunity in early childhood. Diabetes Care 2003; 26:3136–41.
Paronen J, Knip M, Savilahti E, Virtanen SM, Ilonen J, Akerblom HK, Vaarala O. Effect of cow’s milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes 2000; 49:1657–65.
Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H. The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. Diabetes 1998; 47:980–4.
Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363:925–31.
Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial–Type 1. Diabetes Care 2005; 28:1068–76.
Leslie RDG, Pyke DA, Denman A. Immunosoppressive therapy in diabetes. Lancet 1985; 1:516.
Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P for the Cyclosporine/Diabetes French Study Group. Cyclosporine increases the rate and length of remissions in insulin dependent diabetes of recent onset: results of a multicentre double-blind trial. Lancet 1986; 2: 119–24.
Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman SE, Harlan DM, Xu D, Zivin RA, Bluestone JA. Anti-CD3 monoclonal antibody in new onset type 1 diabetes mellitus. N Engl J Med 2002; 346:1692–8.
Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, Hale G, Gorus F, Goldman M, Walter M, Candon S, Schandene L, Crenier L, De Block C, Seigneurin JM, De Pauw P, Pierard D, Weets I, Rebello P, Bird P, Berrie E, Frewin M, Waldmann H, Bach JF, Pipeleers D, Chatenoud L. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005; 352:2598–608.
Bisikirska B, Colgan J, Luban J, Bluestone JA, Herold KC. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J Clin Invest 2005; 115:2904–13.
Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, Chatenoud L.TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9:1202–8.
Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S, Cohen IR. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and down-regulates autoimmunity to various beta-cell antigens. Diabetes 1997; 46:758–64.
Raz I, Elias S, Avron A, Tamir M, Metzger M, Cohen IR. B-cells function in new onset type 1 diabetes and immunomodulation with heat-shock protein peptide (DiaPep277): a randomised, double blind phase II trail. Lancet 2001; 358: 1749–53.
Kobayashi T, Maruyama T, Shimada A, Kasuga A, Kanatsuka A, Takei I, Tanaka S, Yokoyama J. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus. Ann N Y Acad Sci 2002; 958:117–30.
Agardh CD, Cilio CM, Lethagen A, Lynch K, Leslie RD, Palmer M, Harris RA, Robertson JA, Lernmark A. Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications 2005; 19:238–46.
Editor information
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this chapter
Cite this chapter
Beyan, H., Leslie, R.D.G. (2007). Type 1 Diabetes Mellitus. In: Weetman, A.P. (eds) Autoimmune Diseases in Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-517-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-59745-517-6_12
Publisher Name: Humana Press
Print ISBN: 978-1-58829-733-4
Online ISBN: 978-1-59745-517-6
eBook Packages: MedicineMedicine (R0)